Loading...
Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy
Duchenne muscular dystrophy (DMD) is a lethal muscle disease caused by dystrophin gene mutation. Conceptually, replacing the mutated gene with a normal one would cure the disease. However, this task has encountered significant challenges due to the enormous size of the gene and the distribution of m...
Saved in:
| Published in: | Mol Ther |
|---|---|
| Main Author: | |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
American Society of Gene & Cell Therapy
2018
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6171037/ https://ncbi.nlm.nih.gov/pubmed/30093306 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ymthe.2018.07.011 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|